Key facts
- This page summarizes Helmut Wolfgang Jeggle's Form 3 filing for BioNTech SE (BNTX).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 18 Mar 2026, 17:39.
Helmut Wolfgang Jeggle - 18 Mar 2026 Form 3 Insider Report for BioNTech SE (BNTX)
- Reporting relationship
- Director
- Issuer ticker
- BNTX
- Reported as of
- 18 Mar 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Humza Bokhari, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Helmut Wolfgang Jeggle filed Form 3 for BioNTech SE (BNTX) on 18 Mar 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001982614
Primary reporting owner
Jeggle Helmut Wolfgang
- Relationship
- Director
- Address
- C/O BIONTECH SE, AN DER GOLDGRUBE 12, MAINZ, GERMANY
- Signature
- /s/ Humza Bokhari, Attorney-in-Fact
- Signature date
- 18 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BNTX
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 332,316
- Date
- 18 Mar 2026
- Ownership
- Direct
BNTX
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 656,951
- Date
- 18 Mar 2026
- Ownership
- See Footnote
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The ordinary shares are held by Salvia GmbH. The Reporting Person is the Chief Executive Officer of Salvia GmbH and may be deemed to beneficially own the ordinary shares held by Salvia GmbH.
SEC remarks
Exhibit List - Exhibit 24 - Power of Attorney